Wednesday, June 19

KUALA LUMPUR: Pharmaceutical company AstraZeneca is expanding its focus on innovative medicines for rare diseases in Malaysia while strengthening engagements with various stakeholders in the healthcare ecosystem.Rare diseases are typically hereditary or genetic in nature or caused by infections and environmental factors.According to Rare Disease International…
Read More

Comments are closed.